Direct oral anticoagulants for cancer associated venous thromboembolisms: a systematic review and network meta-analysis.
Chinthaka Bhagya SamaranayakeJames J AndersonColm McCabeSyeda Farah ZahirJohn W UphamGregory KeirPublished in: Internal medicine journal (2020)
DOACs are effective in treating malignancy associated VTE, however caution is required in patients with high risk of bleeding. Apixaban had lower risk of bleeding compared to other DOACs in this population. This article is protected by copyright. All rights reserved.